# Eosinophilic Esophagitis Clinical Therapy Comparison Trial

> **NCT01821898** · PHASE2 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 3 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Oral Budesonide
- **OTHER:** Elimination diet

## Key facts

- **NCT ID:** NCT01821898
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07-09
- **Primary completion:** 2018-09-24
- **Final completion:** 2018-09-24
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Recruitment was below expectation
- **Last updated:** 2021-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01821898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01821898, "Eosinophilic Esophagitis Clinical Therapy Comparison Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01821898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*